Genmab
GMAB
GMAB
211 hedge funds and large institutions have $1.58B invested in Genmab in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 67 increasing their positions, 84 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4.58% less ownership
Funds ownership: 65.1% → 60.53% (-4.6%)
17% less capital invested
Capital invested by funds: $1.89B → $1.58B (-$314M)
20% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 84
Holders
211
Holding in Top 10
1
Calls
$292K
Puts
$288K
Top Buyers
| 1 | +$6.95M | |
| 2 | +$5.92M | |
| 3 | +$5.5M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$4.06M |
| 5 |
Optiver Holding
Amsterdam,
Netherlands
|
+$2.75M |
Top Sellers
| 1 | -$57.2M | |
| 2 | -$32.8M | |
| 3 | -$20.8M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$18.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$10.5M |